
【Introduction】
Product Name: Human Integrin aL / ITGAL / CD11a Antibody (Efalizumab, Research Use)
Catalog Number: NBR-0781
Target Name: Integrin aL / ITGAL / CD11a
Trade Name: Efalizumab
Antibody Drug Description: Efalizumab is a recombinanthumanized monoclonal antibodythat binds to the a-subunit (CD11a) ofleukocyte-function-associated antigen1(LFA1), a member of the integrinfamily of cell-adhesion molecules thatis expressed on all leukocytes.
【Description】
Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS:N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG
【Gene Information】
Gene Name: ITGAL
Synonyms: CD11A; LFA-1
Target Description: Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. Integrin ITGAL/ITGB2 is a receptor for F11R. Integrin ITGAL/ITGB2 is a receptor for the secreted form of ubiquitin-like protein ISG15; the interaction is mediated by ITGAL.
Ensembl: ENSG00000005844
Uniprot: P20701